Addressing Barriers to Patient Care for People Living With Atopic Dermatitis
By Leigh Gallo, Victoria Loo, MPH, Scott Shields, MBA
Atopic dermatitis (AD) is a chronic disease that causes itchy, dry, and inflamed skin to approximately 9.6 million children and 16.5 million adults in the US. The condition is highly heterogeneous – disease progression and symptoms will vary between all patients. Patients often experience delayed diagnoses and are unable to access appropriate treatments due to the heterogeneity of the disease and barriers to accessing care. These barriers may lead to less-than-optimal health outcomes and increased healthcare costs.
As the treatment landscape for AD continues to evolve and advance, it is essential that patients have access to effective treatments that can improve patient symptoms and reduce the impact of AD on a patient’s daily life.
As the treatment landscape for AD continues to evolve and advance, it is essential that patients have access to effective treatments that can improve patient symptoms and reduce the impact of AD on a patient’s daily life.
Download our issue brief to learn more about the following:
- The characteristics of AD and the current treatment landscape
- The barriers patients, particularly those with moderate-to-severe AD, encounter when accessing care and approved treatments, including advanced systemic therapies
- The pathways, policies, and payer changes that could improve patient access to appropriate, timely care
